Atlas Trials

Randomized Phase II Trial of Chemoembolization and Sorafenib

Clinical trial NCT02908165 · WITHDRAWN

Trial details

NCT number
NCT02908165
Sponsor
Yale University
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2016-06-01
Primary completion
2020-06-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.